Source: The Economic Times

AVEO: Opioid drugs row: Aveo Pharma claims to have due licences

Aveo Pharmaceuticals, a Mumbai-based drugmaker, faces regulatory scrutiny for exporting addictive opioid drugs to West Africa. Despite claims of having proper licenses, the central and Maharashtra drug administrations have issued notices to stop production. The company is also involved in various other businesses, including construction and film production, under the Al Arabi group.

Read full article »
Est. Annual Revenue
$25-100M
Est. Employees
100-250
Michael P. Bailey's photo - President & CEO of AVEO

President & CEO

Michael P. Bailey

CEO Approval Rating

83/100

Read more